12 Global Issues in Pediatric Rheumatology Flashcards

1
Q

JIA subset reported as the MC in SEA

A

ERA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Developing vs developed countries: JIA more linked to environment and may be autoinflammatory in nature

A

Developing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MC extraarticular manifestation of JIA

A

Uveitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

sJIA is often misdiagnosed as what other rheumatologic disease

A

Rheumatic fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is JAMLess

A

Mgt recommendations for less-resourced countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T/F Asians and Africans have a higher prevalence of lupus nephritis than Caucasians

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Conditions that complicate diagnosis of JIA in less-resourced countries

A

1) Tb
2) Sickle cell anemia
3) HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The way forward to improve outcomes for children with rheuma disease in developing world

A

Have all stakeholders invest in it:
1) Long-term plan to increase # of pedia rheuma
2) Improve access to health care by the govt
3) Increase public awareness of the diseases for early and appropriate treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F In some cases, it is possible to coopt a traditional healer into the multidisciplinary team for religious and social support

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The JAMLess guidelines recommend the inclusion of ___ in the ddx of sJIA

A

Infections like malaria and typhoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The JAMLess guidelines suggest considering JIA in patients being treated presumptively for (3)

A

Tb
RF
HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Organizations that have made it an ethical requirement for pharmas conducting research in less-resourced countries to provide posttrial access to the investigational drug

A

PRINTO and PRCSG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly